ResearcherNational Institutes for Food and Drug ControlActive in the last 2 years

Shufang Meng

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0009-0001-9535-2660; OpenAlex author ID A5100756212.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2025: 1 paper

Papers 1

IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models. Last author DOI 10.3389/fimmu.2025.1664289 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Chongfeng Xu · 1 shared paper, 2025
- Paper IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models. DOI 10.3389/fimmu.2025.1664289 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.